BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12455305)

  • 1. Pharmacokinetics and safety of continuously applied lidocaine patches 5%.
    Gammaitoni AR; Alvarez NA; Galer BS
    Am J Health Syst Pharm; 2002 Nov; 59(22):2215-20. PubMed ID: 12455305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing.
    Gammaitoni AR; Davis MW
    Ann Pharmacother; 2002 Feb; 36(2):236-40. PubMed ID: 11847940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of application durations and heat on the pharmacokinetic properties of drug delivered by a lidocaine/tetracaine patch: a randomized, open-label, controlled study in healthy volunteers.
    Marriott TB; Charney MR; Stanworth S
    Clin Ther; 2012 Oct; 34(10):2174-83. PubMed ID: 22943969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of lidocaine in dogs following lidocaine patch application.
    Ko J; Weil A; Maxwell L; Kitao T; Haydon T
    J Am Anim Hosp Assoc; 2007; 43(5):280-3. PubMed ID: 17823477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of anorectal nifedipine and lidocaine (lignocaine) ointment following haemorrhoidectomy: an open-label, single-dose, phase IV clinical study.
    Perrotti P; Dominici P; Grossi E; Antropoli C; Giannotti G; Cusato M; Regazzi M; Cerutti R
    Clin Drug Investig; 2009; 29(4):243-56. PubMed ID: 19301938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of systemic absorption of lidocaine from 5% patches placed on horses.
    Bidwell LA; Wilson DV; Caron JP
    Vet Anaesth Analg; 2007 Nov; 34(6):443-6. PubMed ID: 17696971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic exposure to lidocaine and tetracaine is low after an application of a lidocaine 7%-tetracaine 7% peel in adults.
    Ogden L; Love G; Basta S
    Int J Dermatol; 2008 Jan; 47(1):87-90. PubMed ID: 18173612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of lidocaine following the application of 5% lidocaine patches to cats.
    Ko JC; Maxwell LK; Abbo LA; Weil AB
    J Vet Pharmacol Ther; 2008 Aug; 31(4):359-67. PubMed ID: 18638297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of lidocaine patches.
    Weil AB; Ko J; Inoue T
    Compend Contin Educ Vet; 2007 Apr; 29(4):208-10, 212, 214-6. PubMed ID: 17726850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of combined intraperitoneal and incisional lidocaine in the dog following ovariohysterectomy.
    Wilson DV; Barnes KS; Hauptman JG
    J Vet Pharmacol Ther; 2004 Apr; 27(2):105-9. PubMed ID: 15096108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proof of systemic safety of a lidocaine ointment in the treatment of patients with anorectal pain.
    Zimmermann J; Schlegelmilch R; Mazur D; Seiler D; Vens-Cappell B
    Arzneimittelforschung; 2007; 57(1):12-9. PubMed ID: 17341004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of high-dose diluted lidocaine in local anesthesia for facelift procedures.
    Ramon Y; Barak Y; Ullmann Y; Hoffer E; Yarhi D; Bentur Y
    Ther Drug Monit; 2007 Oct; 29(5):644-7. PubMed ID: 17898657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated Maximal Safe Dosages of Tumescent Lidocaine.
    Klein JA; Jeske DR
    Anesth Analg; 2016 May; 122(5):1350-9. PubMed ID: 26895001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the depth and duration of anesthesia from heated lidocaine/tetracaine (Synera) patches compared with placebo patches applied to healthy adult volunteers.
    Wallace MS; Kopecky EA; Ma T; Brophy F; Campbell JC
    Reg Anesth Pain Med; 2010; 35(6):507-13. PubMed ID: 20975464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of a lidocaine patch 5% in dogs.
    Weiland L; Croubels S; Baert K; Polis I; De Backer P; Gasthuys F
    J Vet Med A Physiol Pathol Clin Med; 2006 Feb; 53(1):34-9. PubMed ID: 16411907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pharmacokinetics of Atomized Lidocaine Administered via the Trachea: A Randomized Trial.
    Takaenoki Y; Masui K; Oda Y; Kazama T
    Anesth Analg; 2016 Jul; 123(1):74-81. PubMed ID: 27088998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of EMLA cream 5% application to oral mucosa.
    Vickers ER; Marzbani N; Gerzina TM; McLean C; Punnia-Moorthy A; Mather L
    Anesth Prog; 1997; 44(1):32-7. PubMed ID: 9481979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacokinetic study of a topical anesthetic (EMLA® ) in mouse soft tissue laceration.
    Al-Musawi A; Matar K; Kombian SB; Andersson L
    Dent Traumatol; 2012 Dec; 28(6):483-7. PubMed ID: 22812663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic evaluation of a nanotechnological topical formulation of lidocaine/prilocaine (nanorap) in healthy volunteers.
    Gagliano-Jucá T; Castelli MR; Mendes GD; Arruda AM; Chen LS; de Oliveira MA; Costa SF; Lopes AG; de Souza W; De Nucci G
    Ther Drug Monit; 2015 Jun; 37(3):362-8. PubMed ID: 25525759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the interaction between argatroban and acetaminophen, lidocaine, or digoxin.
    Inglis AM; Sheth SB; Hursting MJ; Tenero DM; Graham AM; DiCicco RA
    Am J Health Syst Pharm; 2002 Jul; 59(13):1258-66. PubMed ID: 12116891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.